Health
Stanford AI designs virus to kill E. coli as Canadian trial prepares personalized phage therapy
Stanford researchers have created the first AI-designed bacteriophage while Unity Health Toronto leads a $25 million international trial testing personalized viruses against drug-resistant infections.
